NANOVIRICIDES, INC. (NNVC) Form 424B5 — Jul 17, 2026
NanoViricides, Inc. has filed a prospectus supplement relating to an at-the-market offering of up to $4,018,069 of its common stock. The offering will be conducted through or to D. Boral Capital LLC, acting as the company's sales agent or principal, with sales made at prevailing market prices.
Key figures
- Gross Proceeds
- 4018069
- Shares Outstanding
- 22982816
- Dilution per share
- 0.99
- Public float value
- 41583701
- Assumed shares offered
- 2660973
- Assumed offering price per share
- 1.51
- Net tangible book value after per share
- 0.52
- Net tangible book value prior per share
- 0.41
- Assumed shares outstanding after offering
- 25643789
Price after filing
1 day: 0.0%7 days: -15.4%30 days: -21.1%
Close on the filing date to close N calendar days later (from $1.75). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.